Clinical and Morphological Features of Dysplasia and Early Gastric Cancer in the Patients with Autoimmune Gastritis

Аim: to analyze a series of cases of dysplasia and early gastric cancer developed in patients with autoimmune gastritis (AIG), and to identify their clinical and morphological features.

Materials and methods. The study included six cases of detection of early gastric cancer on the background of AIG. Four out of six patients underwent endoscopic treatment, and in three out of six cases patients underwent endoscopic mucosectomy with dissection in the submucosal layer. One patient underwent endoscopic surgery in 2017, he continues annual dynamic follow-up without signs of tumour recurrence. A female patient with type 1 neuroendocrine tumour and mild dysplasia is awaiting treatment.

Results. In five out of six patients with AIG, the localization of lesions prevailed in the stomach body, while all detected tumours were early ones, and according to the immunophenotype — of a gastric type. The presented cases of tumours were not accompanied by hyperplasia of neuroendocrine cells directly in the area of the tumour itself, but only in the surrounding gastric mucosa. Additionally, several cases of early gastrointestinal stromal tumours were found, which were characterized by low proliferative activity and had small sizes.

Conclusion. The predominance of pseudopyloric metaplasia in the surrounding mucosa allows us to consider pseudopyloric metaplasia as a potentially significant change in the gastric mucosa of patients with AIG that may precede the development of gastric cancer.

1. Sung H., Ferlay J., Siegel R.L., Laversanne M., Soerjo-mataram I., Jemal A., et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49. DOI: 10.3322/caac.21660

2. Lauren P. The two histological main types of gastric carcinoma: Diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand. 1965;64:31–49. DOI: 10.1111/apm.1965.64.1.31

3. Correa P., Piazuelo M.B. The gastric precancerous cascade. J Dig Dis. 2012;13(1):2–9. DOI: 10.1111/j.1751-2980.2011.00550.x

4. Pimentel-Nunes P., Libanio D., Marcos-Pinto R., Areia M., Leja M., Esposito G., et al. Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG), European Society of Pathology (ESP), and Sociedade Portuguesa de Endoscopia Digestiva (SPED) guideline update 2019. Endoscopy. 2019;51(4):365–88. DOI: 10.1055/a-0859-1883

5. Ivashkin V.T., Maev I.V., Lapina T.L., Fedorov E.D., Sheptulin A.A., Trukhmanov A.S., et al. Clinical recommendations of Russian Gastroenterological Association and RENDO Endoscopic Society on diagnosis and treatment of gastritis and duodenitis. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2021;31(4):70–99 (In Russ.). DOI: 10.22416/1382-4376-2021-31-4-70-99

6. Lenti M.V., Rugge M., Lahner E., Miceli E., Toh B.H., Genta R.M., et al. Autoimmune gastritis. Nat Rev Dis Primers. 2020;6(1):56. DOI: 10.1038/s41572-020-0187-8

7. Bizzaro N., Antico A., Villalta D. Autoimmunity and gastric cancer. Int J Mol Sci. 2018;19(2):377. DOI: 10.3390/ijms19020377

8. Vannella L., Lahner E., Osborn J., Annibale B. Systematic review: Gastric cancer incidence in pernicious anaemia. Aliment Pharmacol Ther. 2013;37(4):375–82. DOI: 10.1111/apt.12177

9. Chen C., Yang Y., Li P., Hu H. Incidence of gastric neoplasms arising from autoimmune metaplastic atrophic gastritis: A systematic review and case reports. J Clin Med. 2023;12(3):1062. DOI: 10.3390/jcm12031062

10. Dilaghi E., Dottori L., Pivetta G., Dalla Bella M., Esposito G., Ligato I., et al. Incidence and predictors of gastric neoplastic lesions in corpus-restricted atrophic gastritis: A single-center cohort study. Am J Gastroenterol. 2023. (Online ahead of print). DOI: 10.14309/ajg.0000000000002327

11. Rugge M., Bricca L., Guzzinati S., Sacchi D., Pizzi M., Savarino E., et al. Autoimmune gastritis: Long-term natural history in naïve Helicobacter pylori-negative patients. Gut. 2023;72(1):30–8. DOI: 10.1136/gutjnl-2022-327827

12. Rodriguez-Castro K.I., Franceschi M., Miraglia C., Russo M., Nouvenne A., Leandro G., et al. Autoimmune diseases in autoimmune atrophic gastritis. Acta Biomed. 2018;89(8–S):100–3. DOI: 10.23750/abm.v89i8-S.7919

13. Graham D.Y., Zou W.Y. Guilt by association: Intestinal metaplasia does not progress to gastric cancer. Curr Opin Gastroenterol. 2018;34(6):458–64. DOI: 10.1097/MOG.0000000000000472

14. Kinoshita H., Hayakawa Y., Koike K. Metaplasia in the stomach-precursor of gastric cancer? Int J Mol Sci. 2017;18(10):2063. DOI: 10.3390/ijms18102063

15. Losik Y.A., Selivanova L.S., Antonova T.V., Lapina T.L., Tertychny A.S., Ivashkin V.T. Morphological diagnostic criteria of autoimmune gastritis. Russian Journal of Gastroenterology Hepatology Coloproctology. 2016;26(5):13–20 (In Russ.). DOI: 10.22416/1382-4376-2016-26-5-13-20

16. Businello G., Angerilli V., Parente P., Realdon S., Savarino E., Farinati F., et al. Molecular landscapes of gastric pre-neoplastic and pre-invasive lesions. Int J Mol Sci. 2021;22(18):9950. DOI: 10.3390/ijms22189950

17. Goldenring J.R., Nam K.T., Wang T.C., Mills J.C., Wright N.A. Spasmolytic polypeptide-expressing metaplasia and intestinal metaplasia: time for reevaluation of metaplasias and the origins of gastric cancer. Gastroenterology. 2010;138(7):2207–10. DOI: 10.1053/j.gastro.2010.04.023

18. Dilaghi E., Baldaro F., Pilozzi E., Conti L., Palumbo A., Esposito G., et al. Pseudopyloric metaplasia is not associated with the development of gastric cancer. Am J Gastroenterol. 2021;116(9):1859–67. DOI: 10.14309/ajg.0000000000001390

19. Goldenring J.R., Mills J.C. Cellular plasticity, reprogramming, and regeneration: Metaplasia in the stomach and beyond. Gastroenterology. 2022;162(2):415–30. DOI: 10.1053/j.gastro.2021.10.036

20. Gullo I., Grillo F., Mastracci L., Vanoli A., Carneiro F., Saragoni L., et al. Precancerous lesions of the stomach, gastric cancer and hereditary gastric cancer syndromes. Pathologica. 2020;112(3):166–85. DOI: 10.32074/1591-951X-166

21. Vanoli A., La Rosa S., Luinetti O., Klersy C., Manca R., Alvisi C., et al. Histologic changes in type A chronic atrophic gastritis indicating increased risk of neuroendocrine tumour development: The predictive role of dysplastic and severely hyperplastic enterochromaffin-like cell lesions. Hum Pathol. 2013;44(9):1827–37. DOI: 10.1016/j.humpath.2013.02.005

22. Pietrantonio F., Miceli R., Raimondi A., Kim Y.W., Kang W.K., Langley R.E., et al. Individual patient data meta-analysis of the value of microsatellite instability as a biomarker in gastric cancer. J Clin Oncol. 2019;37(35):3392–400. DOI: 10.1200/JCO.19.01124